Kangmei Pharma | 600518 - Current Assets


Kangmei Pharma reported CNY6.66B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Akebia Therapeutics USD 229.55M 13.93M Jun/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Avita Medical AUD 35.49M 760K Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Genomma Lab Internacional MXN 14.24B 1.04B Sep/2026
Hypermarcas BRL 6.71B 663.99M Mar/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Jiangsu Hengrui CNY 54.55B 4.95B Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Moderna USD 5.82B 45M Jun/2026
Organon & Co USD 5.37B 258M Sep/2026
Revvity USD 2.3B 169.4M Jun/2026
Sh Fosun Pharma CNY 34.54B 256.11M Sep/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.06B 861.1M Jun/2026
Wuxi Apptec CNY 81.79B 8.64B Sep/2026
Xeris Pharmaceuticals USD 274.76M 23.08M Jun/2026
Zz Pientze Pharmaceu CNY 11.16B 270.46M Jun/2026